Prexa Pharmaceuticals' Series B - II Round

Prexa Pharmaceuticals raised a round of funding on May 11, 2011.

Prexa Pharmaceuticals develops product candidates designed to enhance the action of the neurotransmitter dopamine, potentially providing new alternatives to treating CNS diseases and disorders such as…

Articles about Prexa Pharmaceuticals' Series B - II Round: